參考文獻/References:
[1] 中華中醫(yī)藥學會.絕經(jīng)后骨質(zhì)疏松癥(骨痿)中醫(yī)藥診療指南(2019年版)[J].中醫(yī)正骨,2020,32(2):1-13.
[2] 中華醫(yī)學會骨質(zhì)疏松和骨礦鹽疾病分會.中國骨質(zhì)疏松癥流行病學調(diào)查及“健康骨骼”專項行動結(jié)果發(fā)布[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2019,12(4):317-318.
[3] 陳銘,徐道明,朱璐,等.基于《黃帝內(nèi)經(jīng)》淺析骨質(zhì)疏松癥的論治[J].中國骨質(zhì)疏松雜志,2020,26(5):727-730.
[4] 趙凡,劉全,吳連國.口服強骨飲聯(lián)合碳酸鈣D3片治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2019,31(4):26-30.
[5] 田丹,許青,李曉宇,等.國內(nèi)外魚降鈣素制劑不良反應(yīng)分析研究[J].上海醫(yī)藥,2017,38(21):38-42.
[6] 李萍.老年骨質(zhì)疏松患者接受雙膦酸鹽治療急性期不良反應(yīng)分析[D].重慶:重慶醫(yī)科大學,2016.
[7] 中華醫(yī)學會婦產(chǎn)科學分會絕經(jīng)學組.中國絕經(jīng)管理與絕經(jīng)激素治療指南(2018)[J].協(xié)和醫(yī)學雜志,2018,9(6):512-525.
[8] 中國老年學學會骨質(zhì)疏松委員會中醫(yī)藥與骨病學科組.中醫(yī)藥防治原發(fā)性骨質(zhì)疏松癥專家共識(2015)[J].中國骨質(zhì)疏松雜志,2015,21(9):1023-1028.
[9] 馬麗英.中藥穴位貼敷致皮膚過敏1例的處理及護理[J].甘肅中醫(yī),2009,22(11):42.
[10] 鄭筱萸.中藥新藥臨床研究指導原則[M].北京:中國醫(yī)藥科技出版社,2002:356-360.
[11] 史曉林,王健,王博,等.虛瘀兼顧——治療原發(fā)性骨質(zhì)疏松癥的基本原則[J].中醫(yī)正骨,2017,29(3):14-16.
[12] 史曉林,梁博程,李春雯.從“因虛致瘀”論原發(fā)性骨質(zhì)疏松癥病機[J].中國中西醫(yī)結(jié)合雜志,2019,39(1):111-114.
[13] 梁偉喬,鐘誠,李宇明.骨質(zhì)疏松癥的中醫(yī)病因病機認識與治療進展[J].中國骨質(zhì)疏松雜志,2020,26(1):135-139.
[14] 吳亞東,魏杰,劉鐘,等.補腎藥物穴位給藥治療骨質(zhì)疏松癥的機理探討[J].中華中醫(yī)藥學刊,2011,29(5):1102-1104.
[15] 李文瑤,余思奕,郭保君,等.基于現(xiàn)代文獻的穴位敷貼臨床治療病癥譜研究[J].中華中醫(yī)藥雜志,2018,33(8):3562-3565.
[16] 李少華,康石發(fā),孫堅鋼,等.穴位貼敷療法治療絕經(jīng)后及老年性骨質(zhì)疏松癥腰背疼痛的研究進展[J].中醫(yī)正骨,2020,32(5):43-45.
[17] 賀艷萍,肖小芹,鄧桂明,等.中藥穴位貼敷作用機理研究概況[J].中國中醫(yī)藥信息雜志,2017,24(3):134-136.
[18] 田碩,苗明三.基于神經(jīng)-內(nèi)分泌-免疫網(wǎng)絡(luò)探討中藥外用作用機制——“三微調(diào)平衡”[J].中國實驗方劑學雜志,2019,25(4):6-12.
[19] 陳勇,張靜莎,陳澤林,等.基于神經(jīng)-內(nèi)分泌-免疫調(diào)節(jié)的天灸作用機制探討[J].遼寧中醫(yī)雜志,2020,47(6):158-160.
[20] 宋亞剛,白明,方曉艷,等.基于“神經(jīng)-內(nèi)分泌-免疫網(wǎng)絡(luò)”中藥外治機制探討[J].中國實驗方劑學雜志,2019,25(7):220-227.
[21] 馬俊義,施振宇,史曉林.穴位貼敷療法對絕經(jīng)后骨質(zhì)疏松患者血清OPG、RANKL和髖部骨密度的影響[J].中國骨質(zhì)疏松雜志,2017,23(7):921-925.
[22] 何康宏,梁博程,李旭云,等.中藥穴位敷貼治療絕經(jīng)后骨質(zhì)疏松癥[J].長春中醫(yī)藥大學學報,2015,31(6):1240-1242.
相似文獻/References:
[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]李學朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):12.
[3]陳冠軍,陳揚,莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[4]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):27.
[5]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(12):19.
[6]項旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(12):20.
[7]史曉林,李春雯,張志強.弱陽離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):5.
[8]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):21.
[9]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的
相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(12):16.
[10]許超,肖魯偉,吳承亮.絕經(jīng)后女性骨質(zhì)疏松癥辨證分型與抑郁焦慮的關(guān)系研究[J].中醫(yī)正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(12):3.
[11]韓艷,溫利平,劉娜,等.補腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):7.
[12]歐國峰,劉鑫,董博,等.絕經(jīng)后骨質(zhì)疏松癥的免疫學研究進展[J].中醫(yī)正骨,2016,28(08):70.
[13]施振宇,劉鐘,陳文亮,等.中醫(yī)綜合療法防治絕經(jīng)后骨量減少的多中心臨床研究[J].中醫(yī)正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(12):1.
[14]梁文娜,李西海,李燦東.血清microRNA與絕經(jīng)后骨質(zhì)疏松癥腎虛證的關(guān)系[J].中醫(yī)正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制絕經(jīng)后骨質(zhì)疏松大鼠骨代謝紊亂的作用機制研究[J].中醫(yī)正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(12):1.
[16]劉晨,李興勇,姚興璋,等.絕經(jīng)后骨質(zhì)疏松癥的流行病學概況及發(fā)病機制研究進展[J].中醫(yī)正骨,2018,30(03):52.
[17]楊依然,劉鐘,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳動物雷帕霉素靶蛋白通路參與絕經(jīng)后骨質(zhì)疏松癥發(fā)生發(fā)展過程中細胞自噬的機制[J].中醫(yī)正骨,2018,30(04):59.
[18]曹俊青,鄭劍南,張麟.右歸丸聯(lián)合阿侖膦酸鈉口服治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證的臨床研究[J].中醫(yī)正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右歸丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(12):20.
[19]李中萬,徐紹俊,楊廣鋼,等.健腎方聯(lián)合碳酸鈣D3咀嚼片(Ⅱ)
治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證[J].中醫(yī)正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健腎方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(12):11.
[20]趙凡,劉全,吳連國.口服強骨飲聯(lián)合碳酸鈣D3片治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(強骨飲)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(12):26.